Multiple evidences showed that increased ACE2 levels and inflammatory cytokine levels were presented in COVID-19 patients (Pinto et al., 2020; Soldo et al., 2020; Zhuang et al., 2020). The gene discussed is ACE2; the disease is COVID-19.